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Background: Pre-exposure prophylaxis (PrEP) is a biomedical tool taken by 
HIV-negative individuals to prevent HIV transmission. (1) HIV prevalence is 
disproportionately high for transwomen and Afro-Caribbean men who have sex 
with men (ACMSM). (2, 3) This suggests that maximising PrEP uptake could be 
fundamental in curbing HIV prevalence, thus social barriers inhibiting its uptake 
warrant a deep understanding. The aim of this critical inquiry is to develop an 
understanding of PrEP social barriers faced by ACMSM and transwomen in the 
United Kingdom (UK). 
Methods: The following databases were used for this critical inquiry: JSTOR, 
PubMed, and Web of Science. Out of the 30 studies identi!ed as potentially relevant, 
10 studies were included in the review. 
Results: PrEP social barriers identi!ed include: stigma, insu"cient awareness, non-
adherence, and suboptimal patient-provider relationships. (4-12) Social situations can 
lead to fear of PrEP stigma, deterring ACMSM from PrEP uptake. (4) A homophobic 
upbringing and racism could shield these individuals from PrEP awareness and 
adherence. Insu"cient PrEP awareness, transphobia and the all-consuming oppression 
transwomen face may reduce PrEP access for transwomen. (9) Intersectionality could 
explain the heightened PrEP social barriers faced by transwomen and ACMSM. (4, 9, 
10, 13)
Conclusion: Social barriers to PrEP uptake are enhanced amongst ACMSM and 
transwomen due to intersectionality. Continued training on intersectionality and 
sexual and gender minorities (SGM) health are essential for enhancing patient-PrEP 
provider relationship, and reducing discrimination from sexual health services. (14) 
Incorporation of SGM sexual health in sex education may alleviate the PrEP stigma 
ACMSM and transwomen face. Increasing policy representation of transwomen may 






Sexual and gender minorities (SGM) are a group of people who 
embody a variety of sexual orientations and genders (Figure 1). (15) 
SGM have faced historical challenges, including but not limited 
to the AIDS epidemic and infringements of their civil rights. (1) 
These widespread social issues continue to be a burden for SGM 
and contribute to health inequalities. The socio-economic inequali-
ties they suffer from lead to restricted health care access, under-rep-
resentation in policies, social isolation, and has also been attributed 
to a heightened risk of contracting COVID-19. (1)
Figure 1: Adapted from Blondeel et al. (15)
*Other includes queer, asexual, men who have sex with men, ques-
tioning, two-spirit, gender variant.
Pre-exposure prophylaxis (PrEP) is an effective oral drug combina-
tion used by HIV-negative people to prevent HIV contraction. (17) 
As well as its biomedical potential, it can have psychosocial benefits 
like sexual liberation. NHS England was the last NHS system in 
Great Britain to commission PrEP (Figure 2). (18) Before its wide-
spread commissioning in England, PrEP was only accessible via the 
IMPACT trial or if privately funded. (18) However, the trial did 
not sufficiently consider high-risk groups (sex workers, transwom-
en, and Afro-Caribbean men who have sex with men (ACMSM)) 
in their study demographics, raising issues on equitable access to 
PrEP for minorities. (19)
Health inequalities disproportionately affect transwomen and 
ACMSM. (1, 2, 20, 21) Coupled with high prevalence of depres-
sion and anxiety, the World Health Organization (WHO) reported 
that transwomen are 49 times more likely to have HIV than the 
non-transwomen population. (2) Despite this, there is a lack of 
awareness of PrEP amongst transwomen. (9, 10)  According to the 
National AIDS Trust, the proportion of Black Africans and Carib-
beans having late HIV diagnoses were 52% and 40% respectively, 
yet they only receive 28.7% and 2.8% of HIV specialist care in the 
United Kingdom (UK) respectively. (3)
Figure 2: Adapted from Terrence Higgins Trust (18)
Social barriers to PrEP uptake continue to be an omnipresent chal-
lenge in the UK. (4, 5, 10-12, 22) A non-exhaustive list of barriers 
include stigma, non-adherence, lack of risk perception, insufficient 
awareness, and a suboptimal patient-provider relationship. These 
barriers can co-exist and have different weightings for various 
groups within SGM. (4, 10, 22) Poor PrEP uptake can increase 
HIV transmission, worsening its prevalence amongst SGM. (23) 
This threatens WHO’s efforts of ending HIV transmission by 2030. 
(2) The lack of improvement in HIV prevalence amongst SGM will 
continue to fuel HIV stigma as the social aftermath of the AIDS 
epidemic prevails to this day. (1)
PrEP gap is a term given to the difference between the propor-
tion of MSM on PrEP and the proportion of MSM who would 
likely take PrEP if given access. (24) In a survey to MSM across 
50 countries in Europe and Central Asia, the EMIS-2017 report 
found the PrEP gap in the UK to be 20%. (25) Another finding 
was that 96.5% of HIV-negative MSM in Europe and Central 
Asia had never heard of PrEP (N=112939). In 2019, HIV trans-
mission in MSM still made up nearly half of the national mode of 
transmission in the UK, while 84% of trans people accessing HIV 
care were transwomen. (3) The EMIS-2017 report findings (25) 
and HIV transmission statistic in the UK (3) necessitate holistic 
approaches in tackling barriers to PrEP uptake. Breaking social 
barriers through challenging social behaviours and expectations is 
thought to have been successful in controlling HIV transmission in 
the United States (US). (26) It is therefore fundamental to identify 
social barriers to PrEP uptake in the UK.
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PrEP stigma refers to prejudice against those taking PrEP, for 
example associating it with being promiscuous or HIV-positive. 
(4, 13) After the IMPACT trial in England, Turner et al. found a 
statistically significant 4.6% rise in STI rates (N=3407), through a 
retrospective study amongst MSM. (27) Hildebrandt et al. con-
ducted a nationwide survey (N=738) looking at the effects of HIV 
lifestyle stigma on public perceptions of PrEP funding. (11) The 
mean level of support for PrEP public funding in the lifestyle stigma 
group (those who are reminded of lifestyle factors associated with 
contracting HIV) is 3.73 (N=105), whereas the control group had 
a mean level support of 3.86 (N=115). When compared to each 
other, no statistical difference was found (p=0.38). 
Witzel et al. investigated PrEP barriers amongst Black MSM 
Londoners and discovered that some participants refuse PrEP as 
they do not want to fulfil stereotypes. (4) One participant high-
lighted the stigma against Black MSM that they are “promiscu-
ous and dominating”. Nakasone et al. conducted semi-structured 
interviews to assess PrEP attitudes of Afro-Caribbean transwomen, 
and established PrEP stigma to be a heavier burden for them, (10) 
consistent with Witzel et al. (4) Two respondents were fearful 
towards institutional stigma and racism when accessing sexual 
health services (SHS) (N=21). This is in addition to their worry 
about people finding out they are on PrEP and associating this with 
having HIV.  Rael et al., who conducted focus groups to amass at-
titudes to PrEP use, had similar findings for transwomen in the US 
(N=18). (13) A transwomen sex worker described an experience of 
a client confronting her about her PrEP medication, demonstrating 
the stigma associated with PrEP use. She mentioned that PrEP use 
could deter her clients, and be destructive to her career.
PrEP adherence
Young et al. discussed PrEP acceptance amongst MSM and African 
communities in Scotland. (22) PrEP stigma determines the level 
of PrEP adherence of participants. “Fear of being caught on PrEP” 
may lead to PrEP non-adherence. The lack of privacy, and a sudden 
change in environment when taking PrEP can intensify this fear. 
Furthermore, a disruption to their daily routine may lead to forget-
ting PrEP intake. An example of this is visiting families for holidays 
or changes in a work schedule. Meanwhile, third parties have been 
found to be beneficial for PrEP adherence if they are aware that 
a participant is on PrEP. (6) Grov et al.’s participants conducted 
semi-structured interviews to identify strategies used by MSM 
to maintain PrEP adherence, and 13% of participants (N=103) 
reported that third parties, who are aware and supportive of them 
taking PrEP, can give them daily reminders for PrEP use.  
A multivariable analysis used by Mannheimer et al. identified 
factors affecting PrEP adherence amongst MSM (7) and showed 
disparities in PrEP adherence between White MSM and AC-
MSM. When compared against each other, the odds ratio for 
PrEP adherence was 0.29 (CI: 0.13-0.66, p<0.0033), showing that 
White MSM had better PrEP adherence. Even after adjusting for 
other factors linked to PrEP adherence, results remain statistically 
significant.  
Studies looking at PrEP adherence amongst transwomen reveal 
additional challenges. (9) In the US, trans-specific factors affecting 
PrEP acceptability were studied by Sevelius et al. through focus 
groups and individual interviews. They found that transwomen had 
a lower power to negotiate PrEP. A respondent described the lim-
ited selection they have for dating so when it comes to sex, they are 
more likely to be submissive to their partners and engage in riskier 
sexual activities. Ultimately, this may explain their struggle to take 
PrEP regularly. 
Owens et al. conducted a qualitative study investigating PrEP ad-
herence determinants amongst MSM. (8) All respondents (N=34) 
believed that quality of PrEP information given by providers affects 
adherence. Some thought that an in-depth instruction on PrEP use 
increased PrEP adherence for them, as opposed to being given an 
“abrupt instruction” to take it daily. Others believed that having a 
good and long relationship with providers has aided PrEP adher-
ence. Similarly, Sevelius et al. established that transwomen found 
PrEP access easier from trans-informed providers due to reduced 
PrEP stigma. (9) In contrast, others were deterred from PrEP access 
due to transphobia from other patients in SHS, as well as providers. 
PrEP awareness 
Frankis et al. conducted a study to understand PrEP aware-
ness amongst Scottish MSM. (12) Their findings supported the 
EMIS-2017 report; (25) 33% of participants were unaware of PrEP 
(N=690). (12) To evaluate factors affecting PrEP awareness, they 
used a bivariate regression analysis to display the factors enhancing 
PrEP awareness (Table 1). 
Table 1: Adapted from Frankis et al. (12)
The ameliorating factor, ‘always/sometimes talked about HIV with 
unprotected anal sex partners’, has significantly increased PrEP 
awareness. From Table 1, regular engagement with SHS increased 
PrEP awareness. Nonetheless, PrEP awareness may not necessar-
ily be positively correlated with PrEP use, as Frankis et al. found 
(OR=1.03, CI: 0.74-1.42, p<0.873). (12) This was consistent with 
Walsh et al. who claimed that there is little evidence for the associa-
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tion between PrEP awareness and PrEP use. (29) Furthermore, 
Nakasone et al. supports this claim for transwomen. (10) 
PrEP awareness is particularly low in ACMSM. (4, 10, 22, 29) 
Witzel et al. found that Black MSM struggle to have conversa-
tions about SGM sexual health with their families. (4) Not only 
that, Black MSM reported experiences of offline and online racism 
amongst SGM communities. Racial isolation was explored by 
Nakasone et al., where they discovered that Black transwomen in 
Glasgow struggle to access sexual health support from the White-
dominated community. (10) Conversely, transwomen in London 
found it comfortable to access support from an ethnically diverse 
community. However, the main finding was most respondents 
were unaware of PrEP campaigns. Those who were PrEP-aware 
mentioned that it would help if PrEP campaigns were inclusive 
of BAME role models and transwomen, consistent with another 
study. (13)  
Sevelius et al. found that only one transwoman knew about PrEP 
(N=30). (9) Respondents believed that differences in awareness is 
due to poor self-eligibility, lack of trans-inclusive PrEP activism, 
and PrEP threatening their femininity. They viewed PrEP to be 
exclusively for white gay men who are safe, and financially stable 
in life. Many felt they did not fit these criteria, leading to lower 
PrEP uptake. Nearly all of the participants highly valued femininity 
and perceived the intake of a ‘masculine’ product to demean their 
identity, making PrEP access uncomfortable and challenging for 
them. Regarding trans-inclusive PrEP campaigns, participants felt 
that transwomen are “an addendum” to MSM representation and 
believed they should have more representation.  
DISCUSSION 
Results show that transwomen and ACMSM may face stronger 
social barriers to PrEP uptake than other SGM groups. (4-10, 12) 
The rise in STI rates after the IMPACT trial (27) may strengthen 
public perception that PrEP encourages promiscuity. This may 
deter SGM from accessing PrEP, to prevent enacted PrEP stigma 
on top of other SGM discrimination. Although there is evidence 
showing positive attitudes towards PrEP funding, (11) further 
studies are required to support this finding. It is necessary to break 
associations between PrEP use and ‘having HIV’, and this can 
be done through general public education. PrEP non-adherence 
amongst ACMSM (7) may demonstrate how health inequalities 
affect PrEP use. For instance, they may have a more demanding 
occupation (30) meaning they de-prioritise PrEP adherence.
One may assume that intersectionality, a term describing the 
interlinked nature of social categorisations, may account for the re-
inforced social barriers ACMSM face. (4) The interactive effects of 
religion and ethnicity may affect the PrEP awareness of ACMSM. 
Belonging to a homophobic family may explain the insufficient 
PrEP awareness due to lack of conversation on MSM sex. (4) An-
other possible effect of this is intensifying internalised homophobia. 
This may explain PrEP non-adherence, as those who conceal their 
SGM identity from friends and families may find it more challeng-
ing to take PrEP in private. (5) PrEP non-adherence, due to lack 
of privacy at home, may worsen amidst COVID-19 restrictions. It 
may benefit individuals if PrEP was taken less frequently and away 
from home. Studies could look at the possibility of administering a 
single dose PrEP injection in a clinical setting. (29) Finally, SGM 
familial acceptance may influence PrEP adherence as support from 
third parties may benefit them through PrEP adherence reminders. 
(6)
A further effect of intersectionality is exemplified through trans-
women. (10) Afro-Caribbean transwomen in London were more 
comfortable accessing sexual health support from peers than 
Glasgow counterparts. This could be due to fear of transphobia (8), 
and the differences in ethnic diversity of the two cities. Intersec-
tionality suggests that being racially excluded in society, coupled 
with experiences of transphobia may both contribute to a weaker 
social network which may lead to insufficient PrEP awareness, and 
therefore not being able to access it.  
A good patient-provider relationship has the potential to boost 
PrEP adherence. (8, 9) SGM may be too anxious to consult with 
a new provider due to PrEP stigma, and fear of disapproval after 
‘coming out’ again. Transwomen may have additional struggles 
of dealing with transphobia from providers, and other patients. It 
can be suggested that MSM and transwomen may benefit from 
consulting with a familiar health care professional.  
Those who talked about HIV with their UAS partners had 
greater PrEP awareness. (12)  This may be due to having a mutual 
understanding of safe sex practices resulting in the empowerment 
of autonomy. The lower power status of transwomen results in a 
reduced ability to negotiate safe sex. (9) This may demonstrate that 
transwomen are disproportionately affected by insufficient PrEP 
awareness due to the impacts of social oppression. Another reason 
is that transwomen are more vulnerable to domestic violence, (20) 
meaning their lack of sexual health autonomy may be exacerbated. 
Increased PrEP awareness alone may not aid uptake as various stud-
ies found no link between increased PrEP awareness and increased 
PrEP use. (10, 12, 31) This suggests that even if SGM are PrEP 
aware, aforementioned social barriers may be more influential, and 
confounding this association; further studies are required to con-
firm this assumption. Risk perception of individuals to HIV could 
influence the weak link between the two variables. 
Insufficient PrEP awareness amongst transwomen is explained by 
preconceived ideas that PrEP is only for MSM. (9) Transwomen 
being ‘an addendum’ to gay and cis-women-specific PrEP cam-
paigns may contribute to this misapprehension. The motivations 
for this may include lack of understanding of trans-specific health 
needs, lack of societal trans-visibility, and under-estimating the 
risk of transwomen to HIV. Overall, this under-representation may 
explain the insufficient data available on transwomen health issues, 
(1) meaning that identifying the needs of transwomen across the 
nation may be difficult. Campaigns must also encourage trans-
women to access support if suffering from domestic violence. (9) 
Social barriers to pre-exposure prophylaxis uptake within sexual and gender minorities in the UK 
Lee Joshua Melo 
69
bsdj.org.uk
This may also combat the lower power of transwomen to negotiate 
safe sex. 
Strengths and limitations 
All studies reviewed were conducted from 2012 onwards after 
the approval of PrEP (18). A notable critique for studies are their 
applicability to ACMSM and transwomen. Excluding studies 
specifically looking at ACMSM, 50% (N=103) and 94% (N=33) 
of participants recruited by Grov et al. and Young et al. were 
white, respectively (5, 6). This suggests that claims regarding PrEP 
adherence may be weaker for ACMSM, creating uncertainties on 
whether they face the challenges of privacy and support network, 
or lackthereof on PrEP adherence.  Oppositely, Mannheimer et al. 
recruited 10% white MSM (N=176) in the USA, (7) meaning the 
representative claim of black MSM having a lower PrEP adher-
ence, compared to their white counterparts, may be transferrable 
to the UK. 
The use of focus groups and individual interviews by  Sevelius et 
al. (9) ensures the expression of personal opinions, dissimilar to 
the sole reliance on focus groups by Young et al. (5) and Rael et 
al., (13) which may have lead to opinions being swayed by more 
dominating participants. However, Sevelius et al. conducted 
their study in the US; (9) and British transwomen may have face 
different challenges with PrEP adherence.  Both Nakasone et al. 
and Witzel et al. are the first to conduct their research in the UK 
(4,10) so finding consistent studies to support PrEP social barriers 
for Afro-Caribbean SGM was difficult. This means the finding’s 
reproducibility cannot yet be confirmed. Furthermore, Nakasone 
et al. recruited participants through SHS (10) so participants may 
be more PrEP aware, and accepting of PrEP. This suggests over-
estimation of claims, posing an issue on the representativeness of 
results to other transwomen in the UK.
CONCLUSION 
This review aimed to deepen understanding of social barriers to 
PrEP uptake amongst SGM, in particular transwomen and AC-
MSM. ACMSM may find PrEP stigma a greater social barrier to 
PrEP uptake due to the racial stereotypes they wish to avoid being 
associated with. (4) This may lead to individuals abstaining from 
PrEP use to avoid the consequences of PrEP stigma. PrEP cam-
paigns encouraging safe sexual liberation could build confidence 
in PrEP uptake amongst MSM. This is particularly pivotal for 
ACMSM and transwomen who are under-represented in existing 
PrEP campaigns. (9,10,13)  
Intersectionality has aided the understanding of the PrEP social 
barriers faced by ACMSM. (4, 5, 10) Exposure to homophobia, 
racism and internalised homophobia may intensify PrEP stigma, 
insufficient PrEP awareness, and PrEP non-adherence. Discrimi-
nation against SGM may be curbed by integrating SGM sexual 
health, and SGM acceptance in heterosexual-focussed sex educa-
tion delivered at schools. Ultimately, education aim to reduce 
PrEP stigma, and boost PrEP uptake amongst ACMSM. 
Transwomen continue to suffer from insufficient PrEP awareness 
and PrEP non-adherence despite being at higher risk of HIV. (9, 
13) Their continued experiences of social oppression (20) could ex-
plain these strengthened social barriers to PrEP uptake. Alleviating 
the social oppression of transwomen through governmental policies 
may lead to increased PrEP uptake. Discrimination from SHS and 
PrEP providers may form a combined barrier to PrEP uptake for 
transwomen and ACMSM. (8, 9)  An in-depth instruction of PrEP 
use by familiar providers may benefit PrEP adherence for trans-
women patients. Providers, as well as future providers, could benefit 
from continued awareness of SGM-specific health needs. Awareness 
of intersectionality and its effects on ACMSM and transwomen 
patients could better prepare providers for consultations. 
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METHODOLOGY                
REPORTING TEMPLATE 
Criteria  For example…  
Databases searched  JSTOR, PubMed, Web of Science  
Search criteria ‘Pre-exposure prophylaxis’ OR ‘HIV prevention 
tool’ AND ‘Stigma’ OR ‘Awareness’ OR 
‘Adherence’ OR ‘patient-provider relationship’ OR 
‘transwomen’ OR ‘Black, Asian, Minority Ethnic’ 
OR ‘Afro-Caribbean men who have sex with men’  
Inclusion criteria  Studies conducted from 2012; studies conducted on 
transwomen; studies conducted on Afro-Caribbean 
MSM; studies conducted in the UK and USA;  
Exclusion criteria  Studies conducted on heterosexual men and 
women; studies conducted on biomedical barriers; 
studies not written in English 
Number of journal articles 
identified from databases 
85 
Number of abstracts screened 
and identified as potentially 
relevant  
30 
Number of journal articles 
included in the review  
10 
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